FDA Clearance for Spectra™ MRSA Chromogenic Medium
go back to news archives Thermo Fisher Scientific Inc. has received FDA clearance for Spectra™ MRSA, with the highest Positive Predictive Value commercially available for MRSA screening, Spectra provides accurate results within 24 hours. The Spectra MRSA test is manufactured, distributed and sold under the Thermo Fisher specialty brand, Remel. Spectra™ MRSA is a selective chromogenic medium intended for use in the detection of nasal colonization of methicillin-resistant Staphylococcus aureus. The easy-to-use, easy-to-read format enables cost-effective MRSA testing with final results within 24 hours, seven days a week. Spectra™ MRSA is the clear choice for screening more patients on more shifts in more hospitals.
|
NOTE: This item is from our 'historic' database and
may contain information which is not up to date.
Source : Remel Inc. View archived contact details
Posted on April 24, 2008
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
USP Chapter <86> and the Move to Recombinant Methods
29 Apr 2025 -
2025 Novogene Sequencing Symposium
8 May 2025 -
Explore the Future of Sterility Testing with Rapid Micro Biosystems®
14 May 2025 -
Understanding USP <73> to Accelerate Sterility Testing for Short-Life Products
14 May 2025 -
British Society For Microbial Technology 40th Anniversary Microbiology Conference
15 May 2025 -
How Is VIDAS® KUBE™ Transforming Food Pathogen Detection?
19 May 2025 -
Sampling and Microbial Testing of Water and Data Trending
20 May 2025 -
European Microbiology Conference and Workshop 2025
20 May 2025 -
Future Labs Live 2025
27 May 2025 -
2025 Endotoxin Testing Summit
10 Jun 2025